Evidence map›Paper›PMID 29658792›Full record

ReviewThe British journal of radiology2018

Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application.

Cristina Müller, Katharina A Domnanich, Christoph A Umbricht, Nicholas P van der Meulen

Open access · hybridAbstract readReview
In one paragraph

Review in The British journal of radiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
13.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 185 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  5. Review
  6. Compact accelerator-based production of carrier-freeEJNMMI radiopharmacy and chemistry · 2025
    Article
  7. Synthesis of DOTA-BasedMethods and protocols · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Nuclear Cross-Section of Proton-Induced Reactions on EnrichedPharmaceuticals (Basel, Switzerland) · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Cristina Müller1 Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institut , Villigen-PSI , Switzerland.
Katharina A Domnanich2 Laboratory of Radiochemistry, Paul Scherrer Institut , Villigen-PSI , Switzerland.
Christoph A Umbricht1 Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institut , Villigen-PSI , Switzerland.
Nicholas P van der Meulen1 Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institut , Villigen-PSI , Switzerland.
Paul Scherrer Institute · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, different radiometals are in use for imaging and therapy in nuclear medicine:

Indexed as

RadioisotopesRadiopharmaceuticalsScandiumTerbiumClinical Trials as TopicHalf-LifeHumansPositron-Emission TomographyTechnology, RadiologicTheranostic NanomedicineTomography, Emission-Computed, Single-PhotonRadioisotopesRadiopharmaceuticalsScandiumTerbium

Identifiers

PMID29658792
PMCPMC6475947
OpenAlexW2802648531

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.